From: Lymphangiogenesis in gastric cancer: function and mechanism
Year | Molecule | Function | Mechanism or associated molecules | References |
---|---|---|---|---|
2010 | NRP2 | Accelerator | NRP2/VEGF-C/VEGFR3 | [20] |
2011 | Shh | Accelerator | Shh/PI3K/Akt/EMT,MMP-9 | [29] |
Id-1 | Inhibitor | – | [140] | |
HGF | Accelerator | HGF/c-Met | [25] | |
iNOS | Accelerator | LVD | ||
2012 | EphA3 | Accelerator | – | [129] |
CXCL1 | Accelerator | CXCL1/NF-Ò¡B, FAK-ERK1/2-RhoA, F-actin | [65] | |
SOX 18 | Accelerator | Â | [141] | |
2013 | CNTN-1 | Accelerator | CNTN-1/VEGF-C, VEGFR-3 | [142] |
ROSI | Inhibitor | ROSI/VEGF-C, VEGFR-3 | [143] | |
2014 | ECM1 | Accelerator | ECM1/LMVD | [144] |
TP | Accelerator | – | [145] | |
KAI1 | Inhibitor | KAI1/MVD, LVD | [146] | |
2015 | MACC1 | Accelerator | MACC1/HGF/c-Met/VEGF-C/D | [27] |
claudin 4 | Inhibitor | – | [147] | |
IL-8 | Accelerator | IL-8/VEGF-C, VEGF-D, VEGFR-3 | [148] | |
2016 | IL-6 | Accelerator | IL-6/JAK-STAT3-VEGF-C | [44] |
RNF180 | Inhibitor | RNF180/VEGF-C, D, CXCL7 | [136] | |
TAMs | Accelerator | VEGF-C, LVD | [118] | |
2017 | PROX1 | Accelerator | PROX1/b-catenin, ERK1/2, p38, JNK | [134] |
KLHL6 | Accelerator | KLHL6/HGF, MMP-2å’ŒVEGF-C | [135] | |
2018 | Kallistatin | Inhibitor | Kallistatin/NF-Ò¡B/VEGF-C | [114] |
COX-2 | Accelerator | COX-2/VEGF-C | [127] | |
PTBP3 | Accelerator | PTBP3/CAV1 | [131] | |
2019 | oxLDL | Accelerator | oxLDL/NF-Ò¡B/VEGF-C | [115] |
Macrophage | Accelerator | VEGF-A/VEGF-C/VEGF-D | [68] | |
HMGB1 | Accelerator | HMGB1/VEGF-D | [149] | |
HOXB9 | Accelerator | HOXB9/VEGF-D | [150] | |
MicroRNA-7 | Inhibitor | MicroRNA-7/NF-κB/VEGF | [151] | |
2020 | GREM1 | Accelerator | GREM1/VEGFC, PDPN, LYVE | [152] |
BMPRs | Accelerator | – | [42] | |
LncRNA-HNF1A-AS1 | Accelerator | LncRNA-HNF1A-AS1/miR-30b-3p/PI3K/AKT | [153] | |
2021 | SOAT1 | Accelerator | SOAT1/SREBP1, SREBP2/VEGF-C | [116] |
2022 | hsa_circ_0000437 | Accelerator | hsa_circ_0000437/HSPA2-ERK | [131] |
lncRNA ANRIL | Accelerator | lncRNA ANRIL/VEGF-C/VEGFR-3 | [154] |